White Willow Bark
Willow bark standardised to 240 mg salicin per day probably beats placebo for short-term low back pain, but the best-conducted osteoarthritis and rheumatoid arthritis trials were negative. It is a weak, slow salicylate — not a natural aspirin equivalent.
What the science says
- Short-term low back pain Moderate evidence
Cochrane rated the evidence moderate quality: two trials (261 participants) found 240 mg salicin/day better than placebo for pain and rescue medication use over 4 weeks, with 120 mg/day giving a weaker, less consistent response.
- Osteoarthritis and rheumatoid arthritis Limited evidence
Two randomised double-blind trials published together in 2004 (127 patients with OA, 26 with RA) gave 240 mg salicin/day for 6 weeks and found no significant benefit over placebo, while the diclofenac control arm did separate from placebo. An earlier smaller positive OA trial has not been reproduced.
- Not an aspirin substitute for cardiovascular protection Limited evidence
Salicin doses used in trials deliver far less salicylate than low-dose aspirin, and a 51-participant comparison found willow bark had only minimal effect on platelet aggregation versus a cardioprotective aspirin dose. Do not use it in place of prescribed antiplatelet therapy.
Dosage & safety
Scientific references
Where to buy
Nutricost, White Willow Bark, 600 mg, 240 Capsules
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Joints & skin
- Curcumin (Turmeric extract) Moderate evidence
- Collagen Peptides Moderate evidence
- Glucosamine Limited evidence
- Biotin (Vitamin B7) Limited evidence
- MSM (Methylsulfonylmethane) Limited evidence
- Chondroitin Sulfate Moderate evidence